0000940394-22-000365.txt : 20220308 0000940394-22-000365.hdr.sgml : 20220308 20220308121659 ACCESSION NUMBER: 0000940394-22-000365 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220308 DATE AS OF CHANGE: 20220308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eaton Vance Enhanced Equity Income Fund II CENTRAL INDEX KEY: 0001308335 IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-229448 FILM NUMBER: 22720919 BUSINESS ADDRESS: STREET 1: TWO INTERNATIONAL PLACE CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-482-8260 MAIL ADDRESS: STREET 1: TWO INTERNATIONAL PLACE CITY: BOSTON STATE: MA ZIP: 02110 424B3 1 eosprosupp.htm EATON VANCE ENHANCED EQUITY INCOME FUND II THRESHOLD SUPPLEMENT DTD 3-8-2022

Filed pursuant to Rule 424(b)(3)
File No. 333-229448

 

EATON VANCE ENHANCED EQUITY INCOME FUND II
Supplement to
Prospectus dated April 22, 2021 and Prospectus Supplement dated April 22, 2021

The following replaces any references, contained either in the Prospectus or the Prospectus Supplement, with respect to the Fund’s: (i) last reported sale price; (ii) net asset value (“NAV”) per Common Share; (iii) percentage premium to NAV per Common Share; (iv) number of Common Shares outstanding; and (v) net assets.

On March 7, 2022, the last reported sale price, NAV per Common Share and percentage premium to NAV per Common Share, were $19.94, $19.24 and 3.64%, respectively. As of March 7, 2022, we had 51,251,208 Common Shares outstanding and net assets of approximately $986,266,430.

The following replaces the last sentence in the first paragraph under “Use of Proceeds” in the Prospectus Supplement:

Assuming the sale of all of the Common Shares offered under this Prospectus Supplement and the accompanying Prospectus, at the last reported sale price of $19.94 per share for our Common Shares on the NYSE as of March 7, 2022, we estimate that the net proceeds of this offering will be approximately $70,755,463 after deducting the estimated sales load and the estimated offering expenses payable by the Fund.

March 8, 2022